Elad Katz

Elad Katz is a skilled biologist and entrepreneur with extensive experience in the biotechnology and pharmaceutical sectors. As the Founder and Chief Technology Officer of Navigate Precision Biology since April 2018, Katz has developed innovative cell-based assays for industry applications. Concurrently serving as Entrepreneurial Lead and Lead Biologist at the University of Dundee, Katz has led projects focused on immune modulation assays and high-throughput screening platforms. Previous roles include Head of R&D at Sartorius Stedim BioOutsource, Senior Scientist at amsbio, and academic positions at prestigious institutions such as the University of Edinburgh, University of Manchester, and University of Pennsylvania, contributing significantly to cancer research and molecular biology. Katz holds a PhD in Immunology from the University of Glasgow and a BSc in Chemistry and Physics from The Hebrew University of Jerusalem.